Taki E
No ORCID on file
· 1 paper in corpus
· active 2019
Top journals
Frequent coauthors
2019
Development of novel bioactive compounds against KRAS and/or BRAF mutant colorectal cancer (CRC) is currently an urgent need in oncology. In addition, single or multitarget kinase inhibitors against MEK/ERK and PI3K/AKT pathways are of pote…